Assignee
CENTAURUS BIOPHARMA CO LTD
CN·7 granted patents·1 pending application·60 citations·filing 2012–2017
Top patents by PatentIndex Score
8 records- 0190US9926299B2Inhibitors of bruton's tyrosine kinaseCENTAURUS BIOPHARMA CO LTD·Filed 2013·Granted Mar 27, 2018·33 cites·9 claims
- 0285US9309211B2Arylalkene derivatives and use thereof as selective estrogen receptor modulatorsCENTAURUS BIOPHARMA CO LTD·Filed 2012·Granted Apr 12, 2016·11 cites·6 claims
- 0383US10561657B2Pyrrolopyrimidine compoundCENTAURUS BIOPHARMA CO LTD·Filed 2015·Granted Feb 18, 2020·3 cites·19 claims
- 0482US9550781B2Kinase modulating compounds, compositions containing the same and use thereofCENTAURUS BIOPHARMA CO LTD·Filed 2012·Granted Jan 24, 2017·9 cites·14 claims
- 0581US10112922B2Inhibitor of bruton's tyrosine kinaseCENTAURUS BIOPHARMA CO LTD·Filed 2015·Granted Oct 30, 2018·4 cites·8 claims
- 0652US10617692B2Pyrrolopyrimidine comprising cyclopentyl substituentCENTAURUS BIOPHARMA CO LTD·Filed 2017·Granted Apr 14, 2020·0 cites·14 claims
- 0745US10155775B2Substituted amino six-membered saturated heteroalicycles as long-acting DPP-IV inhibitorsCENTAURUS BIOPHARMA CO LTD·Filed 2016·Granted Dec 18, 2018·0 cites·19 claims
- 0836US2018346418A1Kinase activity regulating compound intermediates preparation methodCENTAURUS BIOPHARMA CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CENTAURUS BIOPHARMA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →